Christophe Bourdon
Director/Board Member en SWEDISH ORPHAN BIOVITRUM AB .
Perfil
Christophe Bourdon is currently a Director at Swedish Orphan Biovitrum AB.
Previously, he served as the Chief Executive Officer at Orphazyme A from 2021 to 2022.
He also held the position of Senior Vice President & General Manager-US Oncology at Amgen, Inc. Mr. Bourdon holds an MBA from the International Institute for Management Development and an undergraduate degree from Institut Supérieur de Gestion.
Cargos activos de Christophe Bourdon
Empresas | Cargo | Inicio |
---|---|---|
SWEDISH ORPHAN BIOVITRUM AB | Director/Board Member | 01/01/2023 |
Antiguos cargos conocidos de Christophe Bourdon.
Empresas | Cargo | Fin |
---|---|---|
ORPHAZYME A/S | Chief Executive Officer | 01/04/2022 |
AMGEN INC. | Corporate Officer/Principal | - |
Formación de Christophe Bourdon.
International Institute for Management Development | Masters Business Admin |
Institut Supérieur de Gestion | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 3 |
---|---|
AMGEN INC. | Health Technology |
ORPHAZYME A/S | Health Technology |
SWEDISH ORPHAN BIOVITRUM AB | Health Technology |
- Bolsa de valores
- Insiders
- Christophe Bourdon